NLRP3 and CINCA syndrome: While approximately half of CINCA patients carry heterozygous gain-of-function mutations in NLRP3 gene (39), 30%–40% harbor NLRP3 mutations in only a small number of somatic cells (4.2%–35.8% of blood cells) (40, 41).